Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

There is an association between long-term exposure to ambient air pollution and increased all-cause and cause-specific hospital admissions.

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

A considerable percentage of patients with SLE experienced delayed access to specialized care, which was associated with organ damage accrual.

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy.

California Gov. Gavin Newsom declared a public health emergency on Wednesday as bird flu continues to spread among the state’s dairy cattle.